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The genetic basis of epidermolysis bullosa, a group of genetic disorders characterized by the mechanically induced formation of skin
blisters, is largely known, but a number of cases still remain genetically unsolved. Here, we used whole-exome and targeted sequencing
to identify monoallelic mutations, c.1A>G and c.2T>C, in the translation initiation codon of the gene encoding kelch-like protein 24
(KLHL24) in 14 individuals with a distinct skin-fragility phenotype and skin cleavage within basal keratinocytes. Remarkably, mutation
c.1A>G occurred de novo and was recurrent in families originating from different countries. The striking similarities of the clinical
features of the affected individuals point to a unique and very specific pathomechanism. We showed that mutations in the translation
initiation codon of KLHL24 lead to the usage of a downstream translation initiation site with the same reading frame and formation of a
truncated polypeptide. The pathobiology was examined in keratinocytes and fibroblasts of the affected individuals and via expression of
mutant KLHL24, and we found mutant KLHL24 to be associated with abnormalities of intermediate filaments in keratinocytes and
fibroblasts. In particular, KLHL24 mutations were associated with irregular and fragmented keratin 14. Recombinant overexpression
of normal KLHL24 promoted keratin 14 degradation, whereas mutant KLHL24 showed less activity than the normal molecule.
These findings identify KLHL24mutations as a cause of skin fragility and identify a role for KLHL24 inmaintaining the balance between
intermediate filament stability and degradation required for skin integrity.Inherited epidermolysis bullosa (EB) is a group of genetic
disorders characterized by skin fragility and blister forma-
tion after trivial mechanical trauma.1 In spite of the
advanced knowledge of the molecular basis of EB and
extensive genetic testing, a number of cases remain genet-
ically unsolved.2–5 The most common EB type, EB simplex
(MIM: 131800, 131960, 131760, 131900, 609352, and
601001), is mainly caused by monoallelic mutations in
KRT5 (MIM: 148040) and KRT14 (MIM: 148066), which
encode keratin 5 and keratin 14, respectively, the major in-
termediate filaments (IFs) expressed in basal keratinocytes
of the epidermis. Most KRT5 and KRT14mutations have a
dominant-negative effect and weaken the mechanical
resistance of keratin IFs in basal epidermal keratinocytes,
resulting in skin cleavage within this epidermal layer.6
Furthermore, mutations in three other genes, PLEC
(MIM: 601282), DST (MIM: 113810), and EXPH5 (MIM:
612878), account for rare subtypes of basal EB simplex
(MIM: 226670, 612138, 131950, 616487, 615425, and
615028).2,7–9
Here, we combined deep phenotyping and whole-
exome sequencing (WES) and identifiedmonoallelic muta-
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 2016 American Society of Human Genetics.611295), encoding kelch-like protein 24 (KLHL24), in 14
individuals from ten families affected by genetically un-
solved EB simplex. The families were unrelated and origi-
nated from Germany, Switzerland, Finland, Qatar, and
Italy. The study included a total of 53 family members,
14 of whom had skin fragility, and 39 of whom were not
affected. The clinical phenotype was remarkably consis-
tent across all affected individuals and allowed for the pre-
diction of a common genotype. In three families (A, B, and
J), the inheritance was autosomal dominant, whereas the
other seven families (C–I) showed simplex cases of disease
(Table S1 and Figures 1 and S1). The clinical features
changed with age, but all children and adults had similar
cutaneous manifestations (compare Figures 1 and S2).
Extensive skin defects were present on the extremities at
birth (aplasia cutis congenita), leaving behind hypopig-
mentation and atrophy with a whirled pattern. General-
ized blistering persisted during childhood and healed
with cutaneous and follicular atrophy, linear and stellate
scars, and hypopigmentation (Figures 1 and S2). Toenails
were fragile and became progressively thicker. The cuta-
neous fragility decreased in adulthood. The adults had dys-
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Figure 1. Clinical Features and Morpho-
logical Examinations of the Skin of Individ-
uals with KLHL24 Mutations
(A) Pictures of individual BIII.1 soon after
birth and at 1 and 6 years of age demon-
strate congenital skin defects, hypopig-
mentation with a whirled pattern, atrophy
and linear scars on the dorsal aspects of the
hands and on the lower legs, and thickened
nails. Arrowheads point to the clinical fea-
tures mentioned above.
(B) Pictures of individual BII.1 show sparse
scalp hair, skin atrophy, palmoplantar
keratoderma, and onychogryphosis of the
toenails.
(C) Pedigree of family B. Dashes indicate
that the mutation was excluded.
(D) H&E staining of skin sections obtained
from the unblistered skin of BII.1 after rub-
bing demonstrates cleavage at the level of
basal keratinocytes, which seem to lyse
and loose adhesion (arrowheads). Scale
bar represents 50 mm.
(E) TEM micrographs of skin samples of
CII.2. The upper panels demonstrate cleav-
age deep in the basal epidermal keratino-
cytes, just above the hemidesmosomes.
Lamina densa of the basement membrane
is indicated by arrows. The right panel is a
4-fold magnification of the marked area.
The lower panel shows keratin IFs (arrows).
(F) Immunofluorescence staining of plectin
and integrin b4 in control skin (Co) and in
skin sections obtained from EII.1. Note the
presence of the markers at the blister base.
Blisters are indicated by asterisks. Scale
bar represents 50 mm.atrophoderma, sparse body hair, progressive diffuse alope-
cia of the scalp, diffuse palmoplantar keratoderma, and
nail changes (shown in Figures 1 and S2 and summarized
in Table S1). The unique characteristics of this phenotype
were hair loss and follicular and cutaneous atrophy and
scarring, features that are not present in persons with
classic forms of EB simplex.
The study was performed according to a protocol
approved by the ethics committee of the University of
Freiburg, and written consent was obtained prior to sample
collection. DNA from blood and cultured cells was
obtained with the QIAmp DNA Mini Kit (QIAGEN). Skin
biopsies of the index subjects and healthy individuals
who underwent surgery were obtained after informed writ-
ten consent was provided and were used for morphological
analyses and cell isolation.
The classification as EB simplex was based on the level of
skin cleavage, which was determined by H&E or transmis-1396 The American Journal of Human Genetics 99, 1395–1404, December 1, 2016sion electron microscopy (TEM) (in
individuals AII.2, CII.2, FIII.2, I II.1,
and JII.2) or by immunofluorescence
staining of markers of the dermal-
epidermal junction (DEJ)10 (in AII.2,
BII.1, BIII.1, CII.2, DIII.1, EII.1, FIII.2,GII.1, HII.1, and JII.2). In the skin samples of all index sub-
jects, splits were found at the level of basal keratinocytes
(Figures 1D–1F). The ultrastructural level of cleavage was
located above the hemidesmosomes, close to the basement
membrane. The morphology of the keratin IFs, the hemi-
desmosomes, and the basement membrane appeared
normal (Figure 1E). Hemidesmosomal proteins, plectin,
and integrin b4 stained at the floor of the blisters
(Figure 1F), and the staining intensity of the DEJ markers
was comparable to that of control skin.
In a candidate approach, genes involved in EB were
sequenced in all index subjects, but no pathogenic
changes were found. WES was then employed in families
A (affected mother AII.2 and daughter AIII.1; and unaf-
fected parents AI.1 and AI.2), B (affected siblings BIII.1
and BIII.2), and E (affected EII.1 and unaffected parents).
WES was performed by BGI with the AgilentSureSelect
All Exon Kit on the Illumina HiSeq 4000 platform. Reads
were aligned to the human reference sequence (UCSC
Genome Browser hg19) with the Burrows-Wheeler Aligner
and trimmed to targeted intervals with Picard.11,12 Of
the total effective bases, 55.40% mapped to target regions
(capture specificity). The mean sequencing depth in target
regions was 130.503. On average, per sequencing indivi-
dual, 99.90% of targeted bases had at least 13 coverage,
and 99.10% had at least 103 coverage. All genomic varia-
tions, including SNPs and indels, were detected by state-
of-the-art software, such as the Genome Analysis Toolkit
HaplotypeCaller (v.3.3.0). After that, the hard-filtering
method was applied to produce high-confident variant
calls. Then, the AnnoDB tool developed by BGI was
applied to perform a series of annotations for variants.
The final variants and annotation results were used in
the downstream advanced analysis. Under the assumption
of dominant inheritance or de novo mutations, variants
were filtered as follows: (1) variants in genes known to
be associated with EB or candidate genes from mouse
models were first verified, (2) common and synonymous
variants were eliminated (>1% in dbSNP, 1000 Genomes,
the NHLBI Exome Sequencing Project [ESP] Exome Variant
Server, and/or the Exome Aggregation Consortium [ExAC]
Browser), (3) predicted pathogenic heterozygous variants
present in affected and absent in unaffected individuals
were selected, and finally, (4) variants or genes present in
all affected individuals of the three unrelated families
were retained for validation. This strategy excluded muta-
tions in any known EB-associated genes and revealed two
heterozygous mutations in the start codon of KLHL24
(GenBank: NM_017644.3 and NC_000003.12): c.1A>G
(p.Met1?) in the affected members of families A and B
and c.2T>C (p.Met1?) in the index subject of family E
(Figures 2A and 2B). The mutations were validated by
Sanger sequencing (primers and details are provided in
Table S2). Furthermore, c.1A>G (p.Met1?) was disclosed
in a heterozygous state in all affected individuals of
families C, D, and F–J but in none of the unaffected rela-
tives. Importantly, by testing a total of 53 individuals,
including the healthy parents of the index subjects, we
provide clear evidence that mutations perfectly segregated
with the phenotype in each family and occurred de novo
(Figures 1C, 2A and 2B, and S1).
Variants c.1A>G and c.2T>C were absent in cohorts
of healthy control subjects in dbSNP, 1000 Genomes,
the Exome Variant Server, and the ExAC Browser. They
were predicted to change the Kozak consensus sequence
and shift the start codon of KLHL24. For both c.1A>G
and c.2T>C, the prediction of Mutation Taster13 was
‘‘disease causing’’ with a probability of 0.99. As a con-
sequence, a downstream translation initiation site with
the same reading frame resulting in a 28-aa-shortened
sequence was predicted in silico (Figure 2C). This hypoth-
esis was experimentally verified by recombinant expres-
sion of normal and mutant KLHL24 cDNA. For validation
of the results and better separation by SDS-PAGE, we de-
signed both full-length and short forms of recombinantThe American JouKLHL24. In brief, full-length KLHL24 cDNA (from cDNA
position 1 to the penultimate codon) and the short form
(from cDNA position 1 to position 409, corresponding to
the first 136 codons) were amplified by PCR with REDTaq
DNA Polymerase (Sigma-Aldrich) (the specific primers
are listed in Table S2). The PCR products were cloned
into the pcDNA3.1∕CT-GFP-TOPO vector, and competent
DH5a E. coli (Thermo Fisher Scientific) were transformed
according to the manufacturer’s instructions. Plasmids en-
coding mutant KLHL24 were obtained by site-directed
mutagenesis with the QuikChange II Kit (Agilent Techno-
logies), specific primers (Table S2), and the pcDNA3.1-
KLHL24 constructs as templates. Site-directed mutagenesis
was performed according to the manufacturer’s instruc-
tions. Positive clones were validated by control PCR, and
sequencing and plasmid DNA was isolated with the
Plasmid Maxi Kit (QIAGEN). HEK293 cells were grown in
DMEM and transfected with the Superfect Transfection
Reagent (QIAGEN) according to the manufacturer’s proto-
col. Protein lysates (25 mM Tris-HCl, pH 7.5, 100 mM
NaCl, 1% NP-40, 1 mM PEFA-Bloc, 10 mM EDTA, and pro-
tease inhibitor cocktail) were obtained 48–72 hr after trans-
fection and used for SDS-PAGE and immunoblot with
antibodies to GFP and GAPDH. In agreement with the pre-
diction, recombinant expression of normal and mutant
KLHL24 cDNA in HEK293 cells confirmed that mutations
c.1A>G and c.2T>Cwere translated into shorter truncated
polypeptides, suggesting that Met29 was used for the initi-
ation of translation: p.Val2_Met29del (Figure 2D).
Very little is known about KLHL24, which encodes
KLHL24, and no related human disease has been reported
so far. KLHL24 has been shown to form homodimers and
to regulate the function of kainate receptors in neu-
rons,14,15 but it has not yet been linked to epidermal integ-
rity. KLHL24 belongs to the BTB/kelch family, which com-
prises a large group of highly conserved proteins involved
in diverse cellular functions, including cytoskeleton inter-
actions, nuclear transcription, and ubiquitination.16–18 In
the N terminus, BTB (bric a brac 1, tramtrack, and broad)
domains facilitate dimerization and protein binding. In
particular, BTB domains bind to cullins, E3 ligase adapters,
to target substrates for ubiquitin-dependent degradation
by the 26S proteasome.19,20 N-terminal truncation due
to the mutations in the translation initiation codon of
KLHL24 can affect functions of this region, such as
dimerization and protein interactions, thus having a domi-
nant-negative effect. Kelch domains form a tertiary struc-
ture of b-propellers, which have a role in binding to
specific proteins targeted for degradation.18 One of the
best-known KLHL proteins, KLHL19 (also known as
Keap1, encoded by KEAP1 [MIM: 606016]), is an oxida-
tive-stress sensor that functions as an adaptor for cullin-
3-based E3 ligase to regulate proteasomal degradation of
the antioxidant transcription factor NRF2.21 Mutations in
several BTB/kelch family members are associated with hu-
man monogenic diseases; for example, monoallelic muta-
tions in KLHL3 (MIM: 605775) cause familial hyperkalemicrnal of Human Genetics 99, 1395–1404, December 1, 2016 1397
Figure 2. Mutations Affecting the Translation Initiation Codon of KLHL24 and Their Consequences
(A and B) Sanger sequencing confirmed the KLHL24mutations and their segregation with the phenotype. Partial KLHL24 sequences of
members of families B (A) and E (B) are shown as examples. Note that in both families, the mutation occurred de novo.
(C) Schematic representation of the predicted usage of a downstream translation initiation codon due to the mutations.
(D) Recombinant expression of GFP-fused normal (KL-GFP) andmutant (KL_1A>G-GFP and KL_2T>C-GFP) full-length and short (cDNA
sequence ending in exon 4) KLHL24 polypeptides detectedwith antibodies to GFP demonstrates slightly fastermigration of themutants.
The molecular weight is indicated on the left side in kDa. The pictures represent three technical and three biological replicates.
(E) RT-PCR with mRNA from keratinocytes of DIII.1 and EII.1 and normal human keratinocytes from two different donors (NHK and
NHK-1) shows that KLHL24 mRNA expression and splicing are not affected by the mutations of the start codon. RT-PCR with primers
to GAPDH was run to control loading. Pictures represent experiments done with three biological replicates. MWM indicates the molec-
ular-weight marker in base pairs.
(F) Distribution of KLHL24 in the cytoplasm and at the periphery of normal human keratinocytes (NHK) and of keratinocytes treated
with scramble siRNA. Staining intensity is reduced in keratinocytes treated with KLHL24 specific siRNA and in DIII.1. Pictures represent
three independent experiments. Scale bars represent 20 mm.
(G and H) Immunostaining of keratins 5, 14, and 15 in skin samples (G) and in keratinocytes (H) from a normal control individual
(Co and NHK) and from DIII.1. Inset in the middle lower panel of (H) is a 2-fold magnification of the marked area. Similar results
were obtained with samples from the other individuals. Scale bars represent 50 mm (G) and 20 mm (H).
(I) Immunoblotting of whole-cell lysates with antibodies to keratins 5, 14, and 15. GAPDH antibodies were used to control loading.
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hypertension (MIM: 614495), KLHL7 (MIM: 611119) mu-
tations are associated with retinitis pigmentosa (MIM:
612943), and KLHL9 (MIM: 611201) mutations lead to
autosomal-dominant distal myopathy.18,22–26 The kelch
domain of KLHL16 (or gigaxonin, encoded by GAN
[MIM: 605379]) has been shown to interact with IF
proteins affected in giant axonal neuropathy (MIM:
256850).27 Gigaxonin, the substrate adaptor of an E3
ubiquitin ligase, emerged as the first IF regulator and is
responsible for controlling the turnover of neurofilaments
in addition to other IFs.28,29 The normal physiological role
of gigaxonin is in the maintenance of cytoskeletal struc-
tures in normal tissues, including the processing of inter-
mediate neural filaments in neural cells and vimentin in
fibroblasts and endothelial cells.30
Thus, we studied the expression of KLHL24 in skin and
skin cells. Normal human keratinocytes were cultured in
keratinocyte growth medium (Invitrogen), and dermal fi-
broblasts were grown in DMEM supplemented with 10%
FCS, 1% L-glutamine, and 1% pyruvate (Invitrogen). Hu-
man normal melanocytes were purchased from PromoCell
and grown in melanocyte growth medium (PromoCell).
RNA was isolated with the RNAeasy Mini Kit (QIAGEN),
transcribed into cDNA with the First Strand cDNA Synthe-
sis Kit (Fermentas), and subjected to RT-PCR (primers are
listed in Table S2). We found expression of KLHL24 in all
main skin cell types: keratinocytes, dermal fibroblasts,
and melanocytes (Figure S3A). Next, immunofluorescence
staining was performed on skin cryosections or on kerati-
nocytes, which were seeded on coverslips, allowed to
adhere and grow for 2 days, fixed with acetone and meth-
anol, and processed as previously described31 (antibodies
are listed in Table S3). In skin and keratinocytes, KLHL24
was detected with a commercially available antibody (Ab-
cam) intracellularly and at the cell periphery, where it
partially colocalized with desmoplakin, a marker of desmo-
somes, and with E-cadherin, a component of adherens
junctions (Figures S3B and S3C).
To assess the molecular consequences of KLHL24 mu-
tations, we generated cell lines from primary cells of
individuals DIII.1 and EII.1 and control individuals by
transduction with the HPV E6E7 genes (the construct
was a kind gift from Dr. Fernando Larcher, and the
helper plasmids were a gift from Dr. Stefanie Lo¨ffek) as
described before.32 Mutations were confirmed in all
cell lines (data not shown). As shown by RT-PCR, the
mutations in the start codon of KLHL24 did not
result in reduced transcription or mRNA decay in kerati-
nocytes or fibroblasts derived from the affected individ-
uals (Figures 2E and S3D). Immunostaining of KLHL24
demonstrated a different staining pattern between
mutant keratinocytes (reduction of the signal in the
cytoplasm and at the cell periphery) and normal human
keratinocytes (Figure 2F). To validate the specificity of
the antibody, we used normal human keratinocytes in
which the expression of KLHL24 had been knocked
down by 75% (Figure S3E) with siRNA duplexes specificThe American Jouto KLHL24 (Table S4) (Eurogentec) and Lipofectamine
2000 (Invitrogen).
Like other kelch-like family members, KLHL24 might
be involved in protein ubiquitination, particularly the
turnover of IF proteins, in a manner similar to that of
gigaxonin. IF turnover is a highly dynamic process
required for maintaining tissue integrity and is impli-
cated in degenerative and regenerative processes.29
Keratin IFs are crucial for maintaining cell and tissue
integrity in that they act as structural scaffolds and are
dynamic enough to sustain several additional processes.
Keratins serve multiple homeostatic and stress-enhanced
mechanical and non-mechanical functions in epithelia,
including the maintenance of cellular integrity, regula-
tion of cell growth and migration, and protection from
apoptosis.33 Keratin IFs display highly dynamic proper-
ties in response to injury, sometimes in the form of
degradation of the keratin IF network.34 Phosphoryla-
tion targets keratin proteins for degradation in these
circumstances, and the turnover is regulated by the
ubiquitin proteasome pathway.34–37
To address the hypothesis that KLHL24mutations affect
the degradation of keratins, we assessed keratins 5 and 14
in skin and cultured keratinocytes. Both keratins stained
positive in skin sections of the individuals with KLHL24
mutations, although cytolysis of basal keratinocytes was
very often observed (Figure 2G). In cultured keratinocytes
of the individuals with KLHL24 mutations, keratin 14
staining (clones LL002 and EP1612Y) appeared disorga-
nized, irregular, and fragmented, whereas keratin 5 (clone
D5/16 B4 and polyclonal antibody), tubulin, and actin
were not significantly changed (Figures 2H and S4A). The
amounts of keratins 5 and 14 were 1.5- to 2-fold higher
in whole-cell lysates33 of KLHL24 mutant keratinocytes
than in control cells (Figure 2I). Similar results were ob-
tained after fractionation of soluble and insoluble pro-
tein33 (data not shown). Because keratin 15, a type I keratin
present in minor amounts in basal keratinocytes, has been
shown to form heterodimers with keratin 538 and have a
compensatory effect on the skin of humans with keratin
14 variants,39 we assessed the expression and abundance
of keratin 15 (clone EPR1614Y) in the skin and keratino-
cytes of affected individuals and found a strong upregula-
tion in comparison with control samples (Figures 2G–2I
and S4B). All together, these findings suggest that muta-
tions leading to N-terminal truncation of KLHL24 affect
basal epidermal keratins, in particular keratin 14.
Next, we used heat stress to challenge the keratin IFs
and induce their disruption in keratinocytes.40 In brief,
cells were grown to subconfluence on coverslips, culture
medium was replaced with prewarmed 43C medium,
and dishes were placed in a 43C incubator for 15 min.
Thereafter, the dishes were placed back at 37C, and
coverslips were fixed with ice-cold methanol and acetone,
air-dried, blocked, and incubated with the primary anti-
bodies. In the keratinocytes of the individuals with
KLHL24 mutations, the abnormalities of keratin 14 werernal of Human Genetics 99, 1395–1404, December 1, 2016 1399
Figure 3. Alterations of Keratin 14 and Ubiquitin in KLHL24 Mutant Cells
(A) Keratin 14 staining was disturbed in keratinocytes of DIII.1. After heat stress, remodeling (perinuclear distribution) and fragmenta-
tion of the keratin IFs was observed in the keratinocytes of DIII.1. Similar results were obtained with keratinocytes of EII.1. Scale bar rep-
resents 20 mm.
(B) Quantification of the percentage of cells (mean values 5 SEM) with disturbed keratin 14 staining (10.10% 5 1.05% of 270 NHK
cells, 42.74% 5 3.43% of 491 DIII.1 cells, 13.93% 5 1.86% of 263 NHK þ heat cells, and 84.8% 5 5.01% of 407 DIII.1 þ heat cells;
***p < 0.001). All data are from independent biological replicates, and statistical analysis was performed with an unpaired t test with
Welch’s correction.
(C) Immunoblots with lysates obtained from NHK and keratinocytes of DIII.1, with and without heat stress, were detected with anti-
bodies to ubiquitin and GAPDH.
(legend continued on next page)
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even more pronounced with perinuclear distribution and
fragmentation, suggesting increased depolymerization41
after stress induction, whereas control cells changed very
little (Figures 3A and 3B). The overall abundance of ubiqui-
tinated proteins increased in control cells after heat stress
but did not change significantly in the cells of the individ-
uals with KLHL24 mutations (Figures 3C and S4C).
Confocal microscopy (LSM510, Carl Zeiss) showed that
ubiquitin colocalized with keratin 14 in cells from a con-
trol individual and a person with EB simplex due to a
mutation affecting keratin 14 (c.373C>T [p.Arg125Cys]).
In contrast, in basal cell-culture conditions, particularly
after heat stress, ubiquitin was not present in the cyto-
plasm and did not colocalize with keratin 14 in the cells
of the individuals with KLHL24 mutations (Figures 3D
and S4C). Because stress-inducible kinase p38 was hyperac-
tivated in keratinocytes from persons with EB simplex
caused by mutations affecting keratin 5 or keratin 14 in
basal culture conditions and further increased after os-
motic or heat stress,42,43 we tested whether this was also
the case in KLHL24 mutant keratinocytes. We observed
augmented phosphorylation of the stress-activated kinase
p38 and, in line with this, an approximately 2-fold in-
crease in the apoptosis (In Situ Cell Death Detection Kit,
TMR red, Roche) of KLHL24mutant keratinocytes in basal
cell-culture conditions and after heat stress (Figure S5).
These results suggest that ubiquitination and subsequent
proteasomal degradation of keratin 14 might be disturbed
in the presence of the KLHL24 mutations and thus result
in cellular stress and apoptosis.
To directly address the effect of normal and mutant
KLHL24 on keratin 14 degradation, we assessed keratin
14 by immunofluorescence staining after recombinant
overexpression of the GFP-tagged normal and mutant
KLHL24 cDNAs in HaCaT keratinocytes.44 Of the cells
overexpressing normal KLHL24, 72% were negative for
keratin 14, supporting the hypothesis that, like gigaxo-
nin,28 KLHL24 promotes IF degradation. In contrast, 41%
of the cells expressing mutant KLHL24 preserved the kera-
tin 14 staining (Figures 3E and 3F), suggesting that the
mutants have a lower ability to promote keratin 14 degra-
dation than the normal molecule.
Finally, a broader role of KLHL24 in the regulation of IFs
is supported by the observation of fragmented vimentin IF
in the fibroblasts of the individuals with KLHL24 muta-
tions, whereas the actin cytoskeleton always appeared
normal (Figure S6).(D) Confocal z stack images of the keratinocytes stained with keratin
markers in the cytoplasm of normal human keratinocytes or keratin
p.Arg125Cys (EBS-K14R125C). In the keratinocytes of DIII.1, ubiqui
represents 20 mm.
(E) HaCat cells were transfected with the normal (KL-GFP) and mutan
with antibodies to keratin 14 (red) and GFP (green). Scale bars repre
(F) The graph represents the percentage of keratin-14-positive cel
normal (KL-GFP) or mutant KLHL24 cDNAs (27.66% 5 5.48% of 16
51.12% 5 5.63% of 147 KL_2T>C-GFP cells; ***p < 0.001 and **p <
analysis was performed with an unpaired t test with Welch’s correct
The American JouWe provide strong genetic data that imply mutations in
the translation initiation codon of KLHL24 as the cause of
a distinct skin-fragility phenotype, which can be classified
as EB simplex given the ultrastructural level of skin cleav-
age. Remarkably, mutation c.1A>G occurred de novo and
was recurrent in families originating from different coun-
tries. The striking similarities of the clinical features point
to a unique and very specific pathomechanism, which re-
mains to be clarified in detail. In this regard, it is expected
that nucleotide changes in the third position of the trans-
lation initiation codon (c.3G>A, c.3G>T, or c.3G>C)
might also result in the same phenotype. We have shown
that KLHL24 is expressed in keratinocytes, dermal fibro-
blasts, and melanocytes (the main cells of the skin) and
that it affects the ubiquitination and probably the protea-
somal degradation of IFs, particularly keratin 14 in kerati-
nocytes and vimentin in fibroblasts. Nevertheless, other
targets and functions cannot be excluded.
The identified mutations lead to the formation of an
N-terminally-truncated polypeptide that interferes with
the physiological function of KLHL24, as shown by recom-
binant expression in HaCaT cells. The mutations do not
alter KLHL24 mRNA levels but rather change the protein
amount and activity. Most data on the plasticity of the
keratin network have been generated with cultured cells
that overexpress fluorescence-tagged keratins, whereas
the processes taking place in functional epithelial tissues
remain largely unknown.45 The abnormalities observed
in authentic mutant keratinocytes include disorganization
and fragmentation of keratin 14, which was more abun-
dant than in control cells, suggesting an abnormal degra-
dation. In the skin, where IF turnover is much lower
than in cell culture, the anomalies demonstrated by immu-
nostaining and TEM were mainly associated with cytolysis
of the basal keratinocytes.
The in vivo turnover of keratins is critical during devel-
opment, when active cell division takes place in response
to environmental stressors, and probably during differenti-
ation of basal keratinocytes to the suprabasal layer. The
observed anomalies of keratin 14 might correlate with
the pronounced skin fragility at birth and the spontaneous
alleviation in adulthood, noted in the KLHL24-mutation-
affected individuals examined in this study. Upregulation
of keratin 15 might also contribute to the keratin network
in mutant keratinocytes, but keratin 5 and keratin 15
filaments cannot provide sufficient mechanical strength
to withstand physical trauma.38 We noted both certain14 and ubiquitin antibodies demonstrate colocalization of these
ocytes of a person with EB simplex due to the keratin 14 variant
tin did not demonstrate any cytoplasmic localization. Scale bar
t KLHL24 cDNAs (KL_1A>G-GFP and KL_ 2T>C-GFP) and stained
sent 20 mm.
ls (mean values 5 SEM) among those expressing recombinant
6 KL-GFP cells, 58.94% 5 5.89% of 120 KL_1A>G-GFP cells, and
0.01). Data are from three independent experiments. Statistical
ion.
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similarities and differences between the biological pheno-
types of keratinocytes with mutations affecting KLHL24
and keratin 14. Of particular interest is the increased p38
phosphorylation observed in KLHL24 mutant keratino-
cytes. It was reported that phosphorylated p38 colocalized
with keratin during mitosis in various stress situations and
in cells producing mutant keratins. In all of these situa-
tions, keratin 8 became phosphorylated on Ser73, a well-
known p38 target site. The p38-dependent signaling is a
major intermediate-filament-regulating pathway with
rapid and reversible effects on keratin phosphorylation
and organization in diverse physiological, stress, and
pathological situations.6,46
Nevertheless, the distinct phenotype associated with
KLHL24 mutations does not overlap the clinical pictures
observed in individuals with EB simplex (MIM: 131760,
131900, 601001, and 131800) due to dominant missense
or recessive null mutations affecting keratin 141 or in
individuals with Naegeli syndrome (MIM: 161000) due to
keratin 14 haploinsufficiency.47 The particular features of
this phenotype (skin atrophy and scarring) could be ex-
plained by increased apoptosis of the keratinocytes, by
anomalies of the fibroblasts’ IFs, and by additional func-
tions of KLHL24.Accession Numbers
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